Anti-lag3 Antibodies And Uses Thereof


The present invention provides antibodies that bind to the T cell co-inhibitor lymphocyte activation gene 3 (LAG3) protein, and methods of use. In various embodiments of the invention, the antibodies are fully human antibodies that specifically bind to LAG3. In some embodiments, the antibodies of the invention are useful for inhibiting or neutralizing LAG3 activity, thus providing a means of treating a disease or disorder such as cancer or viral infection.

CPC Classifications
Download PDF
Document Preview
Document History
  • Publication: Apr 13, 2017
  • Application: Oct 7, 2016
    WO US 2016/0056156 W
  • Priority: Jul 21, 2016
    US US 201662365006 P
  • Priority: Jul 8, 2016
    US US 201662359921 P
  • Priority: Mar 30, 2016
    US US 201662315119 P
  • Priority: Nov 20, 2015
    US US 201562257791 P
  • Priority: Oct 9, 2015
    US US 201562239524 P

Download Citation

Sign in to the Lens